توقعات سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا حتى عام 2030 - التحليل الإقليمي - حسب المنتج (الكواشف والأدوات)، والطريقة (الطرق الفيروسية، والطرق غير الفيروسية، والطرق الهجينة)، والتطبيق (الأبحاث الطبية الحيوية، وإنتاج البروتين، والتوصيل العلاجي) والمستخدم النهائي (الأكاديميون ومعاهد البحوث وشركات الأدوية والتكنولوجيا الحيوية)
زيادة شعبية العلاج بالخلايا والجينات تعزز سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا
تصنيع العلاج بالخلايا والجينات هي عملية معقدة، مما يجعل تنفيذها ومراقبتها أمرًا بالغ الأهمية. أدى التقدم في التكنولوجيا الحيوية إلى اعتماد علاجات شخصية لعلاج العديد من المؤشرات. تُستخدم العلاجات الخلوية والجينية في الغالب لعلاج الأمراض المزمنة مثل الاضطرابات العصبية والسرطان والاضطرابات الوراثية. تشمل المزايا الجديرة بالملاحظة للعلاج بالخلايا والجينات العلاج المستهدف والشفاء الأسرع والأكثر كفاءة وتقليل الآثار الجانبية. يتم اعتماد العلاجات الخلوية والجينية على نطاق واسع في جميع أنحاء العالم بسبب توفر المنتجات المعتمدة من إدارة الغذاء والدواء (FDA). على سبيل المثال، وافقت إدارة الغذاء والدواء الأمريكية (FDA) على الفيروس الغدي ADSTILADRIN الذي تم تصنيعه بواسطة شركة Ferring Pharmaceuticals A/S في عام 2022. يقوم هذا الفيروس الغدي المؤتلف (rAd-IFNa/Syn3) بتوصيل الإنترفيرون البشري alfa-2b cDNA إلى ظهارة المثانة لعلاج المرضى الذين يعانون من أنواع معينة من سرطان المثانة. . وفي عام 2022، تمت الموافقة أيضًا على CARVYKTI، الذي تصنعه شركة Janssen Biotech, Inc.، من قبل إدارة الغذاء والدواء. CARVYKTI عبارة عن خلية CAR-T ذاتية المنشأ تم تصميمها باستخدام الفيروس البطيء لمهاجمة الخلايا السرطانية التي تعبر عن BCMA لعلاج أنواع معينة من المايلوما المتعددة الانتكاسية أو المقاومة للعلاج. يستخدم العلماء في الوقت الحاضر تقنية ترنسفكأيشن لإنتاج هذه العلاجات. ومن ثم، فإن الارتفاع المتزايد في شعبية أنشطة العلاج بالخلايا والجينات يؤدي إلى زيادة عدد إجراءات ترنسفكأيشن التي يتم إجراؤها، والتي بدورها تعزز نمو سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا. نظرة عامة على كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا
تصنف منطقة الشرق الأوسط وأفريقيا إلى المملكة العربية السعودية وجنوب أفريقيا والإمارات العربية المتحدة وبقية دول الشرق الأوسط وأفريقيا. تمتلك المملكة العربية السعودية أكبر حصة سوقية في عام 2022.
إن نمو صناعة الأدوية في الشرق الأوسط وإفريقيا مدفوع على نطاق واسع بالاستثمارات التي تقوم بها شركات الأدوية متعددة الجنسيات في دول مثل المملكة العربية السعودية وجنوب إفريقيا والولايات المتحدة. الإمارات العربية المتحدة، وأكثر من ذلك. وفي يناير 2023، وقعت وزارة الاستثمار السعودية مذكرتي تفاهم لتحسين التعاون المشترك مع صناعتي التكنولوجيا الحيوية والأدوية في المملكة. وقعت الوزارة اتفاقية مع شركة Boehringer Ingelheim الألمانية لتعزيز صناعة الأدوية. أما مذكرة التفاهم الثانية فقد تم توقيعها مع شركة نوفو نورديسك السعودية وجامعة الملك عبدالله للعلوم والتقنية بهدف المساهمة في تقديم حلول لتنمية الوعي المجتمعي حول مفاهيم الاضطرابات الأيضية والسمنة والسكري. ومن المرجح أن تؤدي مثل هذه الجهود المبذولة لتوعية الناس بالحالات الطبية النادرة والمزمنة إلى تعزيز سوق كواشف ومعدات ترنسفكأيشن في المملكة العربية السعودية في السنوات القادمة. علاوة على ذلك، فإن الشراكات بين الشركات في هذه البلدان تدفع نمو السوق، في ديسمبر 2021، أعلنت Secondcell Bio و Alliance Care Technologies International عن شراكة استراتيجية جديدة لإنشاء منشأة بحثية جديدة ومتطورة تركز على العلاج بالخلايا و اكتشاف دواء سريع لمكافحة الأمراض الوراثية النادرة في الإمارات. تتقدم تقنية Chromovert كثيرًا على تقنية CRISPR، ولديها إمكانات واسعة لتبسيط عملية اكتشاف الأدوية من خلال تمكين توليد الخلايا التي تم تصميمها مسبقًا لتحسين اكتشاف الأدوية.
إيرادات سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا وتوقعاتها حتى عام 2030 (مليون دولار أمريكي)
تجزئة سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا
الشرق الأوسط يتم تقسيم سوق كواشف ومعدات ترنسفكأيشن في أفريقيا بناءً على المنتج والطريقة والتطبيق والمستخدم النهائي والبلد.
استنادًا إلى المنتج، ينقسم سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا إلى كواشف وأدوات. استحوذ قطاع الكواشف على حصة أكبر في عام 2022.
من حيث الطريقة، يتم تقسيم سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا إلى طرق فيروسية، وطرق غير فيروسية، وطرق هجينة. استحوذ قطاع الأساليب غير الفيروسية على الحصة الأكبر في عام 2022. ويتم تصنيف الجزء الفيروسي إلى فيروسات قهقرية وفيروسات غدية وفيروسات غدية مرتبطة وفيروس الهربس. وينقسم الجزء غير الفيروسي إلى طريقة فيزيائية/ميكانيكية وطريقة كيميائية. علاوة على ذلك، يتم تصنيف جزء الطريقة الفيزيائية/الميكانيكية إلى Electroporation لل، والحقن المجهري، والطريقة البيولوجية، وطريقة الليزر، وmagnetofection، وsonoporation. أيضًا، يتم تصنيف جزء الطريقة الكيميائية إلى قسمين: أساسه دهني/عالي الدهون، وغير دهني/عالي الدهون. من خلال التطبيق، يتم تقسيم سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا إلى أبحاث الطب الحيوي، وإنتاج البروتين، وتقديم العلاج. استحوذ قطاع الأبحاث الطبية الحيوية على الحصة الأكبر في عام 2022.
استنادًا إلى المستخدم النهائي، ينقسم سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا إلى أكاديميين ومعاهد بحثية وشركات الأدوية والتكنولوجيا الحيوية. استحوذ قطاع الأكاديميين ومعاهد البحوث على حصة أكبر في عام 2022.
استنادًا إلى البلد، يتم تصنيف سوق كواشف ومعدات نقل العدوى في الشرق الأوسط وأفريقيا إلى جنوب إفريقيا والمملكة العربية السعودية والإمارات العربية المتحدة وبقية دول الشرق الأوسط. شرق أفريقيا. هيمنت المملكة العربية السعودية على سوق كواشف ومعدات ترنسفكأيشن في الشرق الأوسط وأفريقيا في عام 2022.
Thermo Fisher Scientific Inc، وPromega Corp، وF. Hoffmann-La Roche Ltd، وBio-Rad Laboratories Inc، وMirus Bio LLC، وQIAGEN NV تعد Merck KGaA وLonza Group AG وMaxCyte Inc من الشركات الرائدة العاملة في سوق كواشف ومعدات نقل العدوى في الشرق الأوسط وأفريقيا.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Middle East & Africa Transfection Reagents and Equipment Market Forecast Analysis
6. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East and Africa Transfection Reagents and Equipment Market -Country Analysis
10.1 Middle East and Africa
10.1.1 Middle East and Africa Transfection Reagents and Equipment Market Overview
10.1.2 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.2.3 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.2.4 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.3 South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.3.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.3.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.3.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.3.2.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.3.2.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3.3 South Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.3.4 South Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.4 United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.4.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.4.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.4.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.4.2.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.4.2.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.4.3 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4.4 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.5 Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.5.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.5.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.5.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.5.2.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.5.2.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.5.3 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.5.4 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Thermo Fisher Scientific Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Promega Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bio-Rad Laboratories Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Mirus Bio LLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck KGaA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lonza Group AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 MaxCyte Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
List of Tables
Table 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation
Table 2. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 45. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Middle East and Africa: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.